2024 Q2 Form 10-Q Financial Statement

#000147793224002997 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $421.2K $19.00 $13.92K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $104.2K
Prepaid Expenses
Receivables $74.20K
Other Receivables
Total Short-Term Assets $1.749M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $43.41K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $796.0K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.749M
Total Long-Term Assets $796.0K
Total Assets $2.545M $19.00 $13.92K
YoY Change 55819.69% -99.86% -51.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $125.4K $94.16K $94.18K
YoY Change 33.18% -0.02% -14.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.392M $879.4K $349.8K
YoY Change 574.58% 151.42% 56.65%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $20.00K $270.0K
YoY Change -92.59% 35.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.392M $879.4K $349.8K
Total Long-Term Liabilities $20.00K $270.0K
Total Liabilities $2.704M $899.4K $619.8K
YoY Change 333.0% 45.12% 46.42%
SHAREHOLDERS EQUITY
Retained Earnings -$159.4K -$5.270M -$4.976M
YoY Change -96.81% 5.9% 4.43%
Common Stock $84.00 $24.00 $12.09K
YoY Change -99.31% -99.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$159.3K -$899.4K -$605.9K
YoY Change
Total Liabilities & Shareholders Equity $2.545M $19.00 $13.92K
YoY Change 55819.69% -99.86% -51.53%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 king Convertible Debts Current
ConvertibleDebtsCurrent
90000 usd
CY2023Q1 king Convertible Debts Current
ConvertibleDebtsCurrent
90000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88569 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-186330 usd
CY2024Q1 king Working Capital Deficiency
WorkingCapitalDeficiency
879413 usd
CY2015Q4 us-gaap Convertible Debt
ConvertibleDebt
20000 usd
CY2015Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.035 pure
CY2015Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.00
CY2016Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.035 pure
CY2016Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.00
CY2016Q3 us-gaap Convertible Debt
ConvertibleDebt
30000 usd
CY2016Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.035 pure
CY2016Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.00
CY2016Q3 us-gaap Convertible Debt
ConvertibleDebt
20000 usd
CY2016Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.035 pure
CY2016Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.00
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-20563 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-17154 usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3868 usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2450 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19604 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-24431 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19604 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
24431 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
19604 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
735264 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
682333 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
735264 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
682333 usd
CY2024Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.25 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.25 pure
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.000 pure
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.000 pure
CY2009Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
4000 shares
CY2009Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2024Q1 us-gaap Decommissioning Liability Noncurrent
DecommissioningLiabilityNoncurrent
20000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001374881
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
241886 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
241886 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
241886 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52375
dei Entity Registrant Name
EntityRegistrantName
Kingfish Holding Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4838580
dei Entity Address Address Line1
EntityAddressAddressLine1
822 62nd Street Circle East
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 105
dei Entity Address City Or Town
EntityAddressCityOrTown
Bradenton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34208
dei City Area Code
CityAreaCode
941
dei Local Phone Number
LocalPhoneNumber
487-3653
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
837972 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1395 usd
CY2024Q1 us-gaap Assets
Assets
19 usd
CY2023Q3 us-gaap Assets
Assets
1395 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
94156 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
94156 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
54369 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
45019 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
90000 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
90000 usd
CY2024Q1 king Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
380000 usd
CY2023Q3 king Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
130000 usd
CY2024Q1 king Advances From Related Party
AdvancesFromRelatedParty
260907 usd
CY2023Q3 king Advances From Related Party
AdvancesFromRelatedParty
173714 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
879432 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
532889 usd
CY2024Q1 king Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
0 usd
CY2023Q3 king Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
250000 usd
CY2023Q3 us-gaap Decommissioning Liability Noncurrent
DecommissioningLiabilityNoncurrent
20000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
20000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
270000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
899432 usd
CY2023Q3 us-gaap Liabilities
Liabilities
802889 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
24 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
24 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4390283 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4390283 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5269720 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5171801 usd
CY2024Q1 king Rescission Liabilities
RescissionLiabilities
-20000 usd
CY2023Q3 king Rescission Liabilities
RescissionLiabilities
-20000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-899413 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-801494 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1395 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
32346 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
32691 usd
us-gaap Professional Fees
ProfessionalFees
84151 usd
us-gaap Professional Fees
ProfessionalFees
73138 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4418 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4418 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
36764 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
32691 usd
us-gaap Operating Expenses
OperatingExpenses
88569 usd
us-gaap Operating Expenses
OperatingExpenses
73206 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
4675 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
4666 usd
us-gaap Interest Expense
InterestExpense
9350 usd
us-gaap Interest Expense
InterestExpense
8476 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4675 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4666 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9350 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8476 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41439 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37357 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-97919 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-81682 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-41439 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-37357 usd
us-gaap Net Income Loss
NetIncomeLoss
-97919 usd
us-gaap Net Income Loss
NetIncomeLoss
-81682 usd
CY2024Q1 king Basic And Diluted Earnings Per Share On Net Loss
BasicAndDilutedEarningsPerShareOnNetLoss
-0.17
CY2023Q1 king Basic And Diluted Earnings Per Share On Net Loss
BasicAndDilutedEarningsPerShareOnNetLoss
-0.15
king Basic And Diluted Earnings Per Share On Net Loss
BasicAndDilutedEarningsPerShareOnNetLoss
-0.40
king Basic And Diluted Earnings Per Share On Net Loss
BasicAndDilutedEarningsPerShareOnNetLoss
-0.34
CY2024Q1 king Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
241886 shares
CY2023Q1 king Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
241886 shares
king Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
241886 shares
king Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
241886 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-801494 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-56480 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-857974 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-41439 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-899413 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-524191 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-44325 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-568516 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-37357 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-605873 usd
us-gaap Profit Loss
ProfitLoss
-97919 usd
us-gaap Profit Loss
ProfitLoss
-81682 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-113124 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9350 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8476 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88569 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-186330 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
87193 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
200000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
87193 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
200000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1376 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13670 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1395 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13916 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
250000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5269720 usd
CY2016Q1 us-gaap Convertible Debt
ConvertibleDebt
20000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-24431 usd

Files In Submission

Name View Source Status
0001477932-24-002997-index-headers.html Edgar Link pending
0001477932-24-002997-index.html Edgar Link pending
0001477932-24-002997.txt Edgar Link pending
0001477932-24-002997-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
king-20240331.xsd Edgar Link pending
king_10q.htm Edgar Link pending
king_ex311.htm Edgar Link pending
king_ex312.htm Edgar Link pending
king_ex321.htm Edgar Link pending
king_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
king-20240331_cal.xml Edgar Link unprocessable
king-20240331_def.xml Edgar Link unprocessable
king-20240331_lab.xml Edgar Link unprocessable
king-20240331_pre.xml Edgar Link unprocessable
king_10q_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable